Heineken N.V. reports the progress of transactions under its current share buyback programme Heineken N.V. reports the progress of transactions under its current share buyback programme Amsterdam, 28 April 2025 - Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) hereby reports transaction details related to the first €750 million tranche of its €1.5 billion share buyback programme as communicated on 12 February 2025. From 21 April 2025 up to and including 25 April 2025 a total of 41,891 shares were repurchased on exchange at an average price of € 77.79. During the same period, 28,004 shar...
argenx received a positive opinion from the CHMP of the EMA for Vyvgart in treating CIDP in adults with progressive or relapsing disease after prior treatment with corticosteroids or immunoglobulins. The European Commission will now decide on the regulatory submission within 60 days. Vyvgart is the first novel CIDP treatment in over 30 years and could potentially be self-administered. This approval is expected to lead to significant sales in the EU, with EU peak sales estimated at $1.1bn (KBCSe...
argenx Announces Positive CHMP Opinion for VYVGART (efgartigimod alfa) Subcutaneous Injection for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) VYVGART® is first-and-only targeted IgG Fc-antibody fragment for CIDPFirst novel mechanism of action for CIDP treatment in more than 30 yearsCHMP positive opinion based on ADHERE data, the largest ever CIDP clinical trial European Commission (EC) decision on marketing authorization application (MAA) expected within approximately two months April 28, 2025, 07:00 AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a...
Heineken N.V. successfully places €900 million of Notes Heineken N.V. successfully places €900 million of Notes Amsterdam, 23 April 2025 - Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) announced that it has successfully placed €900 million of 7.5-year Notes with a coupon of 3.276% yesterday. The Notes will be issued under the Company's Euro Medium Term Note Programme and will be listed on the Luxembourg Stock Exchange. The proceeds from the Notes issuance will be used for general corporate purposes, including debt repayments. The maturity date of the Notes is 29 October 2032. ABN Amro, B...
Heineken N.V. reports the progress of transactions under its current share buyback programme Heineken N.V. reports the progress of transactions under its current share buyback programme Amsterdam, 22 April 2025 - Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) hereby reports transaction details related to the first €750 million tranche of its €1.5 billion share buyback programme as communicated on 12 February 2025. From 14 April 2025 up to and including 18 April 2025 a total of 42,011 shares were repurchased on exchange at an average price of € 75.85. During the same period, 56,247 sh...
Heineken N.V. Annual General Meeting adopts all proposals Heineken N.V. Annual General Meeting adopts all proposals Amsterdam, 17 April 2025 - Heineken N.V. (HEINEKEN) announced today that its Annual General Meeting of Shareholders (AGM) has adopted all proposals on the agenda of the AGM. The key resolutions are listed below. Re-appointment of Executive Board MemberThe AGM re-appointed Harold van den Broek as member of the Executive Board for a period of four years, until the end of the AGM to be held in 2029. Dividend The AGM adopted the dividend proposal for the year 2024 of EUR 1...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.